 GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector Atishay Ltd empanelled as Business Associate with RailTel
Atishay Ltd empanelled as Business Associate with RailTel 
              The Committee of Directors (Allotment) of Sun Pharmaceutical Industries Ltd at its meeting held today i.e. on Tuesday, September 26, 2017 allotted 1,106 (One Thousand One Hundred and Six) equity shares of the Company of Re 1/- each, on exercise of stock options under the SUN Employee Stock Option Plan-2015.
Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs. 2,39,93,08,086/- (Rupees Two Hundred and Thirty Nine Crores Ninety Three Lakhs Eight Thousand and Eighty Six Only) divided into 2,39,93,08,086/- (Two Hundred and Thirty Nine Crores Ninety Three Lakhs Eight Thousand and Eighty Six Only) equity shares of Re.1/- each.
Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.507.45 as compared to the previous close of Rs. 505.9. The total number of shares traded during the day was 865802 in over 3387 trades.
The stock hit an intraday high of Rs. 515 and intraday low of 504.55. The net turnover during the day was Rs. 444103263.